Marc E Weksler
Medical Practice in Tenafly, NJ
License number
New Jersey 25MA03141600
Issued Date
Sep 4, 1976
Category
Medical Examiners
Type
Medical Doctor
Address
Address
Tenafly, NJ
Professional information
T Cell Factors Influencing B Cell Development
US Patent:
5686577, Nov 11, 1997
Filed:
Oct 17, 1994
Appl. No.:
8/323910
Inventors:
Marc E. Weksler - Tenafly NJ
Paul Szabo - Linden NJ
Paul Szabo - Linden NJ
Assignee:
Cornell Research Foundation, Inc. - Ithaca NY
International Classification:
A61K 3819, C07K 1452
US Classification:
530351
Abstract:
The present invention relates to an isolated protein or polypeptide capable of production by T cells and capable of ultimately activating production of B cells. The present invention further provides an isolated DNA molecule encoding the protein or polypeptide capable of production by T cells and capable of ultimately activating production of B cells. The isolated DNA molecule can be inserted as a heterologous DNA in an expression vector forming a recombinant DNA expression system for producing the protein or polypeptide. Likewise, the heterologous DNA can be incorporated in a cell to achieve this objective. The isolated protein or polypeptide of the present invention can be combined with a pharmaceutically-acceptable carrier or used alone for administration to mammals for activating production of B cells.
Catalytic Immunoglobulins Bbk32 And Uses Therefor
US Patent:
2009029, Dec 3, 2009
Filed:
Jul 13, 2006
Appl. No.:
11/988761
Inventors:
Sudhir Paul - Missouri City TX, US
Yasuhiro Nishiyama - Houston TX, US
Carl V. Hanson - Berkley CA, US
Marc Weksler - Tenafly NJ, US
Yasuhiro Nishiyama - Houston TX, US
Carl V. Hanson - Berkley CA, US
Marc Weksler - Tenafly NJ, US
International Classification:
A61K 39/395
US Classification:
4241571, 4241301
Abstract:
The present invention describes the composition of class and subclass selected pooled human immunoglobulins with catalytic activity, methods of preparation thereof, and therapeutic utility thereof.